Ruhuna-Duke Centre, Faculty of Medicine, University of Ruhuna, Galle, Sri Lanka Mon-Fri 9am-5pm, Weekend Closed
Call Now
+94 912 234 801 (Ext 429)
RDCID
Mail Now
duke.ruhuna@gmail.com

Initiation of our latest study-Covid-19 and dengue cross reactivity

imgimg
"Determination of biomarkers of disease severity in Covid-19 patients and rates of dengue cross reaction"  sample and data collection were initiated a few weeks ago.         The study team comprises investigators from University Ruhuna Sri Lanka, Duke-NUS Medical School Singapore, and Duke University USA.         The objective of the study is to determine the prevalence of dengue false-positive IgM in Covid-19 patients and to identify biomarkers of severe Covid-19. Patients who are hospitalized for Dengue, Covid-19 and other respiratory infections are being enrolled in the study.
img
img


Created On: August 27, 2024, 4:37 pm

RDCID

Leading infectious disease research institute fostering collaboration, innovation, and impactful solutions worldwide

University of Ruhuna, Galle, Sri Lanka

+94 912 234 801 (Ext 429)

duke.ruhuna@gmail.com

Quick Links

About Us Our Gallery Administration Opportunities Contact Us

Recent Publications

Dengue, Leptospirosis, and Other Febrile Illness Respiratory Infections Antimicrobial Resistance and Stewardship Occupational Health and Community Medicine

© Ruhuna-Duke Centre for Infectious Diseases. All Rights Reserved.

Developed by Webnifix